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Abstract 
 
Objective: The objective of this selective EBM review is to determine the effect of cocoa 
flavanol consumption on cognitive behavior. 
 
Study Design: Systematic review of three English language randomized, double blind, controlled 
clinical trials published in 2010, 2011, and 2012. 
 
Data sources: Three double blind randomized controlled trials comparing cognitive function after 
consumption of drinks with high cocoa flavanol level were found using PedMed and Ovid. 
 
Outcomes measured: Cognitive function was measured by various tests: a Cognitive Demand 
Battery composed of two serial subtraction tasks, a Rapid Visual Information processing task, a 
mental fatigue scale over 1 hour, the Mini Mental Status Examination, Trail Making Test, a 
verbal fluency test, and a visual spatial working memory for location task. 
 
Results: The RCT conducted by Desideri et al found the groups who consumed cocoa flavanol 
had a significantly reduced time to complete the Trail Making test and significantly improved 
verbal fluency test scores compared with the control. The study did not find significant change in 
the Mini Mental State examination after cocoa flavanol ingestion. The Scholey et al study found 
there there were variable changes in the Cognitive Battery Demand testing. With Serial Three 
subtractions there were statistically significant effects of cocoa flavanol with a greater number 
correct and fewer errors compared with the control. With the Serial Sevens task and Rapid 
Visual Information processing tasks there were not any significant differences between the 
control and the group who consumed cocoa flavanol. The Field et al study showed participants 
who consumed cocoa flavanol had a statistically significant improvement on visual spatial tasks 
and a faster reaction time than the control.  
 
Conclusions: The evidence is inconclusive whether there is an effect of cocoa flavanols on 
cognitive function. Future studies collecting data on the effect of habitual consumption of cocoa 
flavanol on cognitive performance could prove most relevant for preventing age related cognitive 
changes. Two of the studies sampled young adults; compiling more trials with adult participants 
would be beneficial to assessing whether cocoa flavanols can prevent or improve age related 
cognitive function decline.  
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Introduction: 
 Cognition is defined as conscious mental activities: the activities of thinking, 
understanding, learning, and remembering. Cognitive impairment is the state of individuals who 
are memory impaired but well-functioning and without evidence of dementia.
1
 Cocoa flavanol 
ingestion is associated with increased cerebral blood flow and brain activation and have been 
proposed to be effective in reversing age related declines in neurocognitive function by 
increasing the number and strength of the connections between neurons, reducing neuronal loss, 
and through their ability to interact with the molecular architecture of the brain responsible for 
memory.
 1
 This paper evaluates three double blind, randomized, controlled trials comparing 
cognitive function after the ingestion of cocoa flavanols.  
 This topic is relevant to PA practice because the US population continues to live longer 
with each generation; therefore, maintaining and enhancing cognitive function is of importance 
as there are commonly age related cognitive declines in attention and short term memory. A 
population based study found 16% of individuals aged 70-89 without dementia to have mild 
cognitive impairment.
2
 Mild cognitive impairment puts individuals at increased risk of 
developing dementia and Alzheimer’s disease. In 2013, Alzheimer’s disease is expected to cost 
the US $203 billion in health care costs.
 3
 Increasing cognitive ability is of relevance to all age 
groups and is beneficial in daily activities and occupational tasks. Screening for cognitive 
function changes is part of the criteria for Medicare’s yearly wellness exam. 4 
 There remains to be much that in unknown in regard to cognitive function impairment as 
it is difficult to predict and is highly variable between individuals. There is no current effective 
prevention or treatment. Flavonoids, found in many plant based foods, may be associated with a 
decreased risk of incident dementia and with lower prevalence of cognitive impairment, a better 
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cognitive evolution over a 10 year period, and better dose dependent performance of several 
cognitive abilities in elderly subjects.
 1 
While there is not yet a standard cure or treatment of cognitive impairment there are 
dozens of dietary supplements marketed as enhancing cognitive function such as gingko biloba, 
phosphatidylcholine, and ginseng.
 4
 Currently, there are no effective preventive strategies for 
cognitive decline. Most research points to modifiable lifestyle factors, such as poor diet and 
physical and cognitive inactivity, as being associated with the risk of dementia. Therefore, 
prevention of cognitive decline is aimed at treating heart disease risk factors such as elevated 
cholesterol, obesity, diabetes, and hypertension.
 5
  
Research has not yielded a cure for cognitive function decline but many natural products 
have been proposed as able to enhance cognition. Cocoa flavanol ingestion is associated with 
increased cerebral blood flow and brain activation so cocoa flavanols may be a safe and natural 
way to increase attention, short term memory, and cognitive function.
 6 
Objective: 
The objective of this selective EBM review is to determine the effect of cocoa flavanol 
consumption on cognitive behavior. 
Methods: 
The three studies utilized were randomized, double blind, controlled clinical trials. The 
populations ranged from 18-30 years old for two of the studies, and alternatively an elderly 
population with mild cognitive impairment was observed in one study. The interventions studied 
in all three RCTs were the consumption of drinks with a high cocoa flavanol level, in 
comparison to groups that consume a drink with a low level of cocoa flavanol. The main 
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outcome measured was cognitive function and secondary outcomes included changes in blood 
pressure and changes in mood. 
 To find data sources I searched PubMed and Ovid with the key words “cocoa flavanol” and 
“cognitive function.” All articles were published in peer-reviewed journals in the English 
language. Articles were selected based on relevance to clinical topic of interest, dates in which 
they were published, and whether they represented patient-oriented evidence that matters. To be 
considered as adequate studies to be reviewed, experimentation was required to involve 
randomized, controlled and double blind clinical trials published after 1996. Exclusion criteria 
included patients diagnosed with dementia. The summary of statistics reported include: p-values 
and F (ANOVA). 
Table 1: Demographics & Characteristics of included studies 
Study Type # 
Pts 
Age (yrs) Inclusion Criteria Exclusion 
Criteria 
W/D Interventions 
Desideri 
(2012)
 1
  
Double-
blind 
randomized  
parallel arm 
study 
90 “elderly” Participants were 
recruited among 
patients referred to 
the Alzheimer unit 
of the University of 
L’Aquila Geriatric 
Division for mild 
cognitive 
impairment (MCI), 
as diagnosed 
according to the 
revised Peterson 
criteria. 
The selection 
criteria for the 
population 
included that 
none of the 
participants 
was obese 
(BMI >30 
kg/m2), a 
current 
smoker, or on 
statin 
treatment.  
3 Consumption of a 
drink containing a 
high level (~990 
mg per serving) of 
cocoa flavanols 
once daily for 8 
weeks or 
consumption of a 
drink containing 
an intermediate 
(~520 mg per 
serving)  or low 
(~45 mg per 
serving) level of 
cocoa flavanols 
once daily for 8 
weeks 
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Scholey 
(2010)
 6
  
Randomized
, controlled, 
double-
blinded, 
balanced, 
three period 
cross-over 
study 
30 18-35 y/o 
(mean 
age: 21.9) 
Undergraduate and 
graduate students 
that were in good 
health, non-
smokers, and who 
abstained from 
cocoa, alcohol, and 
caffeine 
consumption for a 
minimum of 12h 
prior to testing 
session. 
Patients who 
used illicit 
drugs and over 
the counter or 
prescription 
medication  
0 Consumption of a 
drink containing 
520 mg or 994 mg 
of cocoa flavanol 
 
 
Field 
(2011)
 7 
RCT 30 18-25 y/o Participants were 
recruited from the 
School 
Undergraduate 
Research panel and 
had normal visual 
acuity or corrected 
to normal with 
glasses. 
Participants 
were excluded 
if they had 
medically 
restricted diet 
or any kind of 
ongoing 
illness. 
0 Consumption of 
dark chocolate 
containing 720mg 
of cocoa flavanol 
 
 
 
Outcomes measured: 
 
 The main outcome measured was cognitive function in all three RCTs. In the Desideri et 
al study, cognitive function after consumption of cocoa flavanol in individuals with mild 
cognitive impairment was measured by the Mini Mental Status Examination, Trail Making Test, 
and a verbal fluency test. Desideri et al measured blood pressure and various metabolic 
parameters as secondary outcomes. Scholey et al assessed cognitive function with a Cognitive 
Demand Battery composed of two serial subtraction tasks, and used the Spielberger state anxiety 
questionnaire to assess anxiety symptoms. Field et al tested each participant at a high and low 
cocoa flavanol level on separate occasions to assess cognitive function. Field et al assessed 
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cognitive function with various tests including a visual spatial working memory task and a 
choice reaction time test designed to engage processes of sustained attention and inhibition. 
Results: 
The RCT conducted by Desideri et al assessed the impact of regular (once daily) cocoa 
flavanol consumption on cognitive function in individuals with mild cognitive impairment in an 
8 week study. Participants were recruited among those referred to the Alzheimer unit of the 
University of L’Aquila Geriatric Division for mild cognitive impairment, and selection criteria 
included that none of the participants were obese, a current smoker, or under statin treatment. 
The participants were divided into a high, intermediate, and low level of cocoa flavanol 
ingestion. The groups were comparable in terms of sex, age, cardiovascular risk factors, and 
pharmacological treatments. The main measurement was cognitive function as assessed by the 
Mini Mental State Examination, Trail Making Test, and a verbal fluency test. Two participants in 
the intermediate group discontinued the study after 4 weeks because of personal reasons and one 
participant in the low ingestion group discontinued after 2 weeks because of reported gastric 
discomfort. All 3 were followed up during the entire study period and data was included 
according to intention to treat procedure. Overall compliance was 99.4% at week 8 and 
adherence to protocol was evaluated at each visit by a questionnaire checklist. The Mini Mental 
State Examination score did not change significantly between the 3 groups during the study 
(p=0.13). The time to complete the Trail Making test significantly reduced in the groups who 
consumed high and intermediate levels of cocoa flavanol but did not change in the low cocoa 
flavanol level group (Table 2). Verbal fluency test scores significantly improved in the groups 
with high and intermediate cocoa flavanol ingestion (Table 3). Systolic and diastolic blood 
pressures significantly changed during the study period with significant reduction in the high and 
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intermediate level flavanol groups. Blood pressure did not change in the group who consumed a 
low level of flavanol (p<0.0001). 
Table 2: Change in time to complete Trail Making Test from week 1 to week 8 (calculated as 
week 8 time minus week 1 time) among groups ingesting high, intermediate, or low cocoa 
flavanol amounts. 
Amount of cocoa flavanol consumed Change in time (seconds) P value 
High (990mg) -14.3±4.2 <.0001 
Intermediate (520mg) -8.8±3.4 <.0001 
Low (45mg) +1.1±13 0.65 
 
Table 3: Verbal fluency score among groups ingesting high, intermediate, or low cocoa flavanol 
amounts. 
Amount of cocoa flavanol consumed Verbal fluency (words/60 seconds) P value 
High (990mg) 8.0±5.3 <.0001 
Intermediate (520mg) 5.1±3.1 <.0001 
Low (45mg) 1.2±2.7 0.014 
 
Table 4: Blood pressure change from week 1 to week 8 among groups ingesting high, 
intermediate, or low cocoa flavanol amounts. 
Amount of cocoa 
flavanol consumed 
Systolic BP change 
(mm Hg) 
P value Diastolic BP 
(mm Hg) 
P value 
High (990mg) -10.1±9.2 <.0001 -4.8±5.3 <0.0001 
Intermediate (520mg) -8.2±8.5 <.0001 -3.4±7.0 <0.0001 
Low (45mg) -1.4±9.4 0.16 -0.9±6.8 0.14 
 
 The RCT conducted by Scholey et al compared consumption of a drink containing 
520mg and 994mg cocoa flavanol and a control drink. The study used healthy undergraduate 
students aged 18-35 years old as subjects and conducting the study on four separate occasions at 
least three days apart for each subject. To assess compliance, salivary caffeine levels were 
measured in order to confirm adherence to caffeine abstinence instructions. To test for baseline 
differences between the groups which may have skewed change from baseline scores, prior to 
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the primary statistical analysis, all pre-dose baseline measures were subjected to one way 
repeated measures ANOVAs. There was not a significant effect of cocoa flavanol consumption 
with the Spielberger state anxiety questionnaire (F<1 in all cases), and there were variable 
changes in the Cognitive Battery Demand testing.  With Serial Three subtractions there were 
statistically significant effects of drink consumption on the number of Serial Threes correct and 
the number of errors with a greater number correct (F=18.6, p <.001) and fewer errors (F=4.67, 
p=0.01) at 20 minutes following 994mg of cocoa flavanol compared with the control. With the 
Serial Sevens task there were not any significant differences between the control and 
consumption of cocoa flavanol (F<1, p>0.1). With the Rapid Visual Information processing tasks 
(RVIP) there were no significant treatment effects on accuracy (F=1.13, p>0.1) but participants 
were significantly faster (F=0.66, p=0.03) at the task. Excluded from the study were patients who 
used illicit drugs or prescription or over the counter medications so as to avoid results that were 
skewed by interactions with medications or illicit drugs. 
 The RCT by Field et al was conducted in the School of Psychology and Clinical 
Language Sciences at the University of Reading and included 30 participants between 18-25 
years old who were recruited from the Undergraduate Research Panel and received course credit 
for their participation.  The study compared participants visual spatial working memory with and 
without cocoa flavanol supplementation and found a significant difference between the two 
conditions (F=3.41, p=0.05). Results showed that with high cocoa flavanol ingestion the groups 
had a greater percent correct on visual spatial tasks (Table 5). In the reaction time assessment the 
participants to consume a high cocoa flavanol drink had a faster reaction time (Table 5) than the 
control. The study excluded participants who reported having medically restricted diet or any 
kind of ongoing illness, and all participants had normal visual acuity or acuity corrected to 
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normal by glasses. For 24 hours prior to study days and during the 2 hour interval between 
consumption and testing participants were asked to avoid consuming a list of foods and drinks 
containing flavonoids , as well as alcohol and caffeine. To increase compliance researchers told 
participants that a cheek swab would be collected and analyzed to check conformity to 
restrictions, however the swab was collected and not analyzed. 
Table 5: Visual spatial and reaction time tasks comparing high cocoa flavanol ingestion and 
control groups. 
Amount of cocoa flavanol consumed High CF Control 
Visual spatial (% correct) 87.13±9.32 83.51±11.16 
Reaction time (ms) 538±149 557±85 
 
 In regards to safety, all three studies did not find evidence of any relevant adverse effects. 
The studies did not quantify adverse effects as there were not any consistent adverse findings to 
be evaluated. A participant in one study, Desideri et al, reported nonspecific gastric discomfort. 
Discussion: 
 The data from Desideri et al found cognitive performance was improved with cocoa 
flavanol consumption and blood pressure, both systolic and diastolic, was decreased. The study 
was a 2 month intervention so the extent and duration of cognitive benefits, and their impact on 
mild cognitive impairment are not known. It is also unclear whether the observed benefits in 
neurocognition are a result of the cocoa flavanols themselves or a “secondary effect related to 
general improvements in cardiovascular function or health.” 1 A limitation was that the study 
population included subjects without known cardiovascular disease and therefore was not 
representative of all subjects with mild cognitive impairment. Overall the results provide 
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evidence that flavanol containing foods could be an effective dietary approach for improving 
aspects of cognitive dysfunction. 
 The results of Scholey et al demonstrate that the acute consumption of cocoa flavanol can 
improve cognitive performance during cognitive processing in healthy young participants. 
Compared with the nutrient matched, low flavanol control drink, some improvements in 
cognition were found after consumption of both the 520mg and 994 mg cocoa flavanol drinks, 
and interestingly the 520mg drink was most beneficial. The data suggests that the Serial Threes 
task draws on different neurocognitive substrates than the Serial Sevens. It is unclear why the 
520mg drink led to better cognitive function with a lower level of cocoa flavanol than the 994mg 
drink. The study was limited by the population’s small age range, between 18 and 35 years old, 
and small sample size of 30 individuals. 
 The results of Field et al demonstrate that performance on tests of visual system function 
in healthy young adults can be improved by acute consumption of cocoa flavanol. A reduction in 
time required to integrate visual motion could be beneficial in everyday tasks like driving. There 
are reasons to predict that the chronic effects of cocoa flavanol supplementation on visual 
function will be larger than the acute effects discussed in the research by Field et al. Dietary 
flavonoids are neuroprotective, enhance the endothelial function, and suppress inflammatory 
processes, all of which would likely be beneficial for the retina and visual cortex.
 7
 Rat models 
suggest that epigallocatechin gallate, a flavonoid from green tea, has a protective effect on the 
neural layer of the retina and accelerates recovery from various insults to the retina.
 7
 The 
findings from Field et al are limited by their basis on visual function in young adults and their 
findings could be extended to investigate the effects of cocoa flavanol on vision in older adults 
since decline in visual processing is associated with aging.  
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 Research has previously shown that flavanol rich chocolate and cocoa products may have 
a small but statistically significant effect in lowering blood pressure by 2-3 mm Hg in the short 
term.
 8
 Yet, the literature notes that long-term trials are needed to determine whether or not blood 
pressure is reduced on a chronic basis by daily ingestion of cocoa. Research is also needed to 
determine the effect of cocoa flavanol on cardiovascular events and to assess potential adverse 
effects associated with chronic ingestion of cocoa products.
 8 
 Conclusion: 
The evidence is inconclusive whether there is an effect of cocoa flavanols on cognitive 
function. It would be of great interest to explore the chronic effects of cocoa flavanol ingestion 
and comparing them to those elicited acutely as in the discussed studies. Future studies collecting 
data on cocoa flavanol’s effect on cognitive performance with habitual consumption could prove 
most relevant for preventing age related cognitive changes. Two of the studies sampled young 
adults between 18 and 35 years old but compiling more trials with adult participants would be 
beneficial to assessing whether cocoa flavanols can prevent or improve age related cognitive 
function decline. It would also be interesting to compare caffeine ingestion to cocoa flavanol 
ingestion in future trials to rule the possibility that the caffeine ingredient in cocoa is contributing 
to its positive effects.
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